These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7511562)
41. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation. Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897 [TBL] [Abstract][Full Text] [Related]
42. Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2. Olive D; Lopez M; Blaise D; Viens P; Stoppa AM; Brandely M; Mawas C; Mannoni P; Maraninchi D J Immunother (1991); 1991 Dec; 10(6):412-7. PubMed ID: 1722705 [TBL] [Abstract][Full Text] [Related]
43. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity. Jabrane-Ferrat N; Calvo F; Faille A; Lagabrielle JF; Boisson N; Quillet A; Fradelizi D Br J Cancer; 1990 Apr; 61(4):558-62. PubMed ID: 2109997 [TBL] [Abstract][Full Text] [Related]
44. Cytotoxic effects on viable human leukemic cells by combinations of lymphokine activated killer cells and monoclonal antibodies. Vasilopoulos G; Sjögren AM; Reizenstein P Leuk Res; 1989; 13(1):87-91. PubMed ID: 2915576 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis. Lobo PI; Chang MY; Mellins E Immunology; 1996 Aug; 88(4):625-9. PubMed ID: 8881767 [TBL] [Abstract][Full Text] [Related]
46. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001 [TBL] [Abstract][Full Text] [Related]
47. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity. Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273 [TBL] [Abstract][Full Text] [Related]
48. A lymphokine-activated killer (LAK)-resistant cell line, and low expression of adhesion molecules LFA-3 and VCAM-1 on its cell surface. Komatsu F; Kajiwara M Oncol Res; 1998; 10(5):263-9. PubMed ID: 9802061 [TBL] [Abstract][Full Text] [Related]
49. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia. Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR Year Immunol; 1993; 7():90-5. PubMed ID: 7690510 [No Abstract] [Full Text] [Related]
50. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1. Jackson AM; Alexandrov AB; Prescott S; James K; Chisholm GD Immunology; 1992 Jun; 76(2):286-91. PubMed ID: 1353063 [TBL] [Abstract][Full Text] [Related]
51. Signal transduction via phosphorylated adhesion molecule, LFA-1 beta (CD18), is increased by culture of natural killer cells with IL-2 in the generation of lymphokine-activated killer cells. Umehara H; Takashima A; Minami Y; Bloom ET Int Immunol; 1993 Jan; 5(1):19-27. PubMed ID: 8095153 [TBL] [Abstract][Full Text] [Related]
52. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma. Munker R; Andreeff M Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699 [TBL] [Abstract][Full Text] [Related]
53. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL. Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814 [TBL] [Abstract][Full Text] [Related]
54. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma. Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474 [TBL] [Abstract][Full Text] [Related]
55. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing. Wiebke EA; Custer MC; Rosenberg SA; Lotze MT J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373 [TBL] [Abstract][Full Text] [Related]
56. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity. Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980 [TBL] [Abstract][Full Text] [Related]
57. A supportive role of neural cell adhesion molecule (NCAM) in adhesion between leukaemic blasts and cytotoxic lymphocytes. Palucka AK; Porwit A; Reizenstein P Scand J Immunol; 1992 Apr; 35(4):399-406. PubMed ID: 1373000 [TBL] [Abstract][Full Text] [Related]
58. Induction of NK and LAK activities in human lymphocyte culture by a cytosol fraction from leukemic myeloblasts and by monoclonal antibody CD 3. Soucek J; Chudomel V; Hrubá A; Lindnerová G Neoplasma; 1991; 38(1):33-41. PubMed ID: 2011208 [TBL] [Abstract][Full Text] [Related]
59. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826 [TBL] [Abstract][Full Text] [Related]
60. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells. Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]